(FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | (Q6)Sep 30, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | 8.22%-37.77M | ---- | -486.38%-41.15M | ---- | -296.64%-7.02M | ---- | 102.81%3.57M | ---- | -45.68%-127.11M | ---- |
Profit adjustment | ||||||||||
Interest (income) - adjustment | -45.65%-5.05M | ---- | 18.88%-3.47M | ---- | 5.29%-4.28M | ---- | -73.42%-4.51M | ---- | -130,050.00%-2.6M | ---- |
Interest expense - adjustment | -12.99%422K | ---- | -1.62%485K | ---- | 20.83%493K | ---- | 11.78%408K | ---- | -24.59%365K | ---- |
Dividend (income)- adjustment | -113.71%-265K | ---- | 38.92%-124K | ---- | -2,800.00%-203K | ---- | 97.86%-7K | ---- | -251.61%-327K | ---- |
Impairment and provisions: | 133.16%2.73M | ---- | 113.45%1.17M | ---- | -578.63%-8.7M | ---- | -107.53%-1.28M | ---- | 708.57%17.03M | ---- |
-Other impairments and provisions | 133.16%2.73M | ---- | 113.45%1.17M | ---- | -578.63%-8.7M | ---- | -107.53%-1.28M | ---- | 708.57%17.03M | ---- |
Revaluation surplus: | -136.78%-12.87M | ---- | 309.56%34.99M | ---- | 166.59%8.54M | ---- | -114.93%-12.83M | ---- | 76.63%85.92M | ---- |
-Other fair value changes | -136.78%-12.87M | ---- | 309.56%34.99M | ---- | 166.59%8.54M | ---- | -114.93%-12.83M | ---- | 76.63%85.92M | ---- |
Asset sale loss (gain): | 2,613.04%45.66M | ---- | -499.34%-1.82M | ---- | -92.35%455K | ---- | -68.57%5.94M | ---- | -27.75%18.91M | ---- |
-Loss (gain) from selling other assets | 2,613.04%45.66M | ---- | -499.34%-1.82M | ---- | -92.35%455K | ---- | -68.57%5.94M | ---- | -27.75%18.91M | ---- |
Special items | ---- | ---- | -14.37%4.48M | ---- | 99.73%5.23M | ---- | --2.62M | ---- | ---- | ---- |
Operating profit before the change of operating capital | -31.23%-7.14M | ---- | 0.60%-5.44M | ---- | 10.13%-5.47M | ---- | 22.07%-6.09M | ---- | 40.39%-7.82M | ---- |
Change of operating capital | ||||||||||
Accounts receivable (increase)decrease | -71.67%6.27M | ---- | 58.37%22.14M | ---- | -12.68%13.98M | ---- | 2.41%16.01M | ---- | -25.39%15.64M | ---- |
Accounts payable increase (decrease) | 161.43%360K | ---- | -658.10%-586K | ---- | 111.85%105K | ---- | -157.91%-886K | ---- | 553.85%1.53M | ---- |
Financial assets at fair value (increase)decrease | 82.22%-33.88M | ---- | -279.71%-190.6M | ---- | -50.33%-50.2M | ---- | 77.93%-33.39M | ---- | -83.13%-151.3M | ---- |
Special items for working capital changes | -77.45%1.2M | ---- | -82.74%5.33M | ---- | 74.66%30.85M | ---- | -86.47%17.66M | ---- | 146.28%130.51M | ---- |
Cash from business operations | -127.10%-21.42M | ---- | 12.15%-9.43M | ---- | -60.38%-10.73M | ---- | 41.50%-6.69M | ---- | 46.90%-11.44M | ---- |
Other taxs | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 142.59%319K | ---- |
Dividend received - operating | 113.71%265K | ---- | -38.92%124K | ---- | 2,800.00%203K | ---- | -97.86%7K | ---- | 251.61%327K | ---- |
Interest received - operating | -62.59%1.1M | ---- | -4.85%2.94M | ---- | 87.27%3.09M | ---- | 164,900.00%1.65M | ---- | -50.00%1K | ---- |
Interest paid - operating | 12.99%-422K | ---- | 1.62%-485K | ---- | -20.83%-493K | ---- | -11.78%-408K | ---- | 24.59%-365K | ---- |
Special items of business | ---- | -401.78%-21.4M | ---- | 105.80%7.09M | ---- | -13.76%3.45M | ---- | 148.51%4M | ---- | 71.02%-8.24M |
Net cash from operations | -198.83%-20.47M | -401.78%-21.4M | 13.65%-6.85M | 105.80%7.09M | -45.74%-7.93M | -13.76%3.45M | 51.22%-5.44M | 148.51%4M | 50.81%-11.16M | 71.02%-8.24M |
Cash flow from investment activities | ||||||||||
Net cash before financing | -198.83%-20.47M | -401.78%-21.4M | 13.65%-6.85M | 105.80%7.09M | -45.74%-7.93M | -13.76%3.45M | 51.22%-5.44M | 148.51%4M | 50.81%-11.16M | 71.02%-8.24M |
Cash flow from financing activities | ||||||||||
Issuing shares | ---- | ---- | 47.72%24.01M | ---- | 141.59%16.25M | ---- | --6.73M | ---- | ---- | ---- |
Issuance expenses and redemption of securities expenses | ---- | ---- | -62.69%-423K | ---- | -356.14%-260K | ---- | ---57K | ---- | ---- | ---- |
Other items of the financing business | ---- | ---- | ---- | 47.47%23.59M | ---- | 139.75%15.99M | ---- | --6.67M | ---- | ---- |
Net cash from financing operations | ---- | ---- | 47.47%23.59M | 47.47%23.59M | 139.75%15.99M | 139.75%15.99M | --6.67M | --6.67M | ---- | ---- |
Net Cash | -222.33%-20.47M | -169.76%-21.4M | 107.64%16.74M | 57.81%30.68M | 556.89%8.06M | 82.24%19.44M | 110.99%1.23M | 229.49%10.67M | 50.81%-11.16M | 71.02%-8.24M |
Begining period cash | 154.26%27.59M | 154.26%27.59M | 288.99%10.85M | 288.99%10.85M | 78.55%2.79M | 78.55%2.79M | -87.72%1.56M | -87.72%1.56M | -64.07%12.72M | -64.07%12.72M |
Cash at the end | -74.22%7.11M | -85.11%6.18M | 154.26%27.59M | 86.81%41.53M | 288.99%10.85M | 81.77%22.23M | 78.55%2.79M | 172.73%12.23M | -87.72%1.56M | -35.73%4.48M |
Cash balance analysis | ||||||||||
Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | -21.95%1.2M | ---- | 71.25%1.53M | ---- |
Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | -23.50%1.2M | ---- | -87.72%1.56M | ---- |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
Auditor | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data